IP Library Granted Patent US 8,580,975
Granted Patent B2
US 8,580,975 · App. 12/812,067 · Granted Nov 12, 2013

Synthesis of macrocyclic cancer chemotherapy agents and methods of use

Inventors: Arun K Ghosh (West Lafeyette, IN); Xiaoming Xu (Dallas, TX)
Assignee: Purdue Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,580,975
App. No.
12/812,067
Granted
Nov 12, 2013
Kind
B2
Abstract

Herein are described a process for forming a quaternary carbon useful in the preparation of macrolactones, an enantioselective synthesis of (+)-peloruside A, and methods for treating a patient in need of relief from cancer or a cancer-related disease. The described processes are useful for preparing compounds containing quaternary carbons, including structural analogs and derivatives of peloruside A.

Claims (45)

1. A process for forming a quaternary carbon between a hydroxymethylene or alkoxymethylene carbon and a ketone (or hemiketal or ketal thereof) carbon or a hydroxymethylene reduction product of said ketone, the process comprising the steps of

reacting a first compound containing an α-alkyl-α,β-unsaturated ketone moiety with a source of nucleophilic hydride, wherein the source of nucleophilic hydride is lithium (sec-butyl) 3 borohydride; and adding a second compound containing an aldehyde to form the quaternary carbon.

2. A process of forming a compound wherein the compound contains a quaternary carbon between a hydroxymethylene or alkoxymethylene carbon and a ketone (or hemiketal or ketal thereof) carbon or a hydroxymethylene reduction product of said ketone comprising the steps of

reacting a first compound containing an α-alkyl-α,β-unsaturated ketone moiety with a source of nucleophilic hydride, wherein the source of nucleophilic hydride is lithium (sec-butyl) 3 borohydride; and adding a second compound containing an aldehyde to form the quaternary carbon.

3. The process of claim 2 wherein the compound containing a quaternary carbon is a bryostatin, a peloruside, a mycalamide or an epothilone.

4. The process of claim 2 wherein the compound containing a quaternary is a macrolactone which has the formula

wherein:

R 1 is

where * shows the point of attachment and R 8 and R 12 are independently hydrogen, alkyl, heteroalkyl, arylalkyl, heteroarylalkyl, or an oxygen protecting group;

R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are each independently selected from the group consisting of hydrogen, alkyl, hydroxy, and alkoxy; and X 1 is hydrogen, hydroxy, alkoxy or together with the carbon to which it is attached forms a carbonyl or an oxime.

5. The process of claim 4 wherein the macrolactone has the formula

wherein:

R 1 is

where * shows the point of attachment;

R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are each independently selected from the group consisting of hydrogen, alkyl, hydroxy, and alkoxy; X 1 is hydrogen, hydroxy, alkyl, alkoxy or together with the carbon to which it is attached forms a carbonyl or an oxime; and

R 8 and R 12 are independently hydrogen, alkyl, heteroalkyl, arylalkyl, heteroarylalkyl, or an oxygen protecting group.

6. The process of claim 5 wherein the macrolactone has the formula

wherein

R 1 is

where * shows the point of attachment;

R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are each independently selected from the group consisting of hydrogen, alkyl, hydroxy, and alkoxy; X 1 is hydrogen, hydroxy, alkyl, alkoxy or together with the carbon to which it is attached forms a carbonyl or an oxime; and

R 8 and R 12 are independently hydrogen, alkyl, heteroalkyl, arylalkyl, heteroarylalkyl, or an oxygen protecting group.

7. The process of claim 6 wherein R 3 is methoxy and R 7 is methoxy.

8. The process of claim 6 wherein R 6 is hydrogen.

9. The process of claim 6 wherein R 2 is hydrogen.

10. The process of claim 6 wherein R 2 is hydroxy; R 4 is methoxy; R 5 is hydroxy; R 6 is hydroxy; X 1 is hydroxy; and

R 1 is

where * shows the point of attachment and R 8 and R 12 are independently hydrogen, alkyl, heteroalkyl, arylalkyl, heteroarylalkyl, or an oxygen protecting group.

11. The process of claim 6 wherein R 2 is hydroxy; R 4 is methoxy; R 5 is hydroxy; R 6 is hydrogen, hydroxy, alkyl, or alkoxy; X 1 is hydroxy; and R 1 is 4-(R)-hydroxymethyl-hex-2-(Z)-ene-2-yl.

12. The process of claim 6 wherein R 2 is hydroxy; R 4 is methoxy; R 5 is hydroxy; R 6 is hydroxy; X 1 is hydrogen, or epi-hydroxy, alkoxy, or alkyl, or X 1 and the attached carbon form a carbonyl; and R 1 is 4-(R)-hydroxymethyl-hex-2-(Z)-ene-2-yl.

13. The process of claim 6 wherein R 2 is hydrogen, hydroxy, or alkyl; R 4 is methoxy; R 5 is hydroxy; R 6 is hydroxy; X 1 is hydroxy; and R 1 is 4-(R)-hydroxymethyl-hex-2-(Z)-ene-2-yl.

14. The process of claim 6 wherein R 2 is hydroxy; R 4 is hydrogen, hydroxy, alkoxy, or alkyl; R 5 is hydroxy; R 6 is hydroxy; X′ is hydroxy; and R 1 is 4-(R)-hydroxymethyl-hex-2-(Z)-ene-2-yl.

15. The process of claim 6 wherein R 2 is hydroxy; R 4 is methoxy; R 5 is hydrogen, hydroxy, alkoxy, or alkyl; R 6 is hydroxy; X 1 is hydroxy; and R 1 is 4-(R)-hydroxymethyl-hex-2-(Z)-ene-2-yl.

16. The process of claim 1 wherein alkyl is C 1 -C 4 alkyl.

17. The process of claim 16 wherein alkyl is methyl.

18. The process of claim 1 wherein a moiety of the following formula

comprises the quaternary carbon formed.

19. The process of claim 1 wherein a moiety of the following formula

comprises the quaternary carbon formed.

20. The process of claim 2 wherein alkyl is C 1 -C 4 alkyl.

21. The process of claim 20 wherein alkyl is methyl.

22. The process of claim 2 wherein a moiety of the following formula

comprises the quaternary carbon formed.

23. The process of claim 2 wherein a moiety of the following formula

comprises the quaternary carbon formed.

Assignments (1)
CONFIRMATORY LICENSE Recorded Nov 17, 2011
From: PURDUE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027244/0977 →
Continuity (2)
Provisional Application 61020498 · Jan 11, 2008
Related Publication 20110028540A1 · Feb 3, 2011